Perspectives on telemedicine to improve stroke treatment

Drugs of Today

Volumn 47, Issue 2, 2011, Pages 157-167

  Stewart, S F ^a   Switzer, Jeffrey A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AUDIOVISUAL EQUIPMENT; BLOOD CLOT LYSIS; COST EFFECTIVENESS ANALYSIS; EMERGENCY CARE; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HEALTH CARE ACCESS; HUMAN; INTENSIVE CARE UNIT; LONG TERM CARE; MALPRACTICE; MEDICAL EDUCATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGY; PATIENT CARE; PERSONNEL SHORTAGE; PROFESSIONAL COMPETENCE; REVIEW; STROKE; TELECOMMUNICATION; TELECONSULTATION; TELEMEDICINE; TELEPHONE; THERAPY DELAY; TREATMENT OUTCOME;

EID: 79955879213     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2011.47.2.1576694     Document Type: Review

References (66)

1. Lloyd-Jones, D., Adams, R.J., Brown, T.M. et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121(7): 948-54.
2. Prevalence of disabilities and associated health conditions among adults-United States, 1999. MMWR Morb Mortal Wkly Rep 2001, 50(7): 120-5.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333(24): 1581-7.
4. Kleindorfer, D., Lindseil, C.J., Brass, L., Koroshetz, W., Broderick, J.P. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 2008, 39(3): 924-8.
5. Hacke, W., Kaste, M., Bluhmki, E. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359(13): 1317-29.
6. Del Zoppo, G.J., Saver, J.L., Jauch, E.C., Adams, H.P., Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40(8): 2945-8.
7. Lees, K.R., Bluhmki, E., von Kummer, R. et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010, 375(9727): 1695-703.
8. Levine, S.R., Gorman, M. "Telestroke" : the application of telemedicine for stroke. Stroke 1999, 30(2): 464-9.
9. Audebert, H.J., Kukla, C., Vatankhah, B. et al. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke 2006, 37(7): 1822-7.
10. Switzer, J.A., Hall, C., Gross, H. et al. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. J Emerg Med 2009, 36(1): 12-8.
11. Meyer, B.C., Raman, R., Hemmen, T. et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol 2008, 7(9): 787-95.
12. Schwamm, L.H., Rosenthal, E.S., Hirshberg, A. et al. Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med 2004, 11(11): 1193-7.
13. Demaerschalk, B.M., Bobrow, B.J., Raman, R. et al. Stroke team remote evaluation using a digital observation camera in Arizona: the initial mayo clinic experience trial. Stroke 2010, 41(6): 1251-8.
14. LaMonte, M.P., Bahouth, M.N., Hu, P. et al. Telemedicine for acute stroke: triumphs and pitfalls. Stroke 2003, 34(3): 725-8.
15. Waite, K., Silver, F., Jaigobin, C. et al. Telestroke: a multi-site, emergency-based telemedicine service in Ontario. J Telemed Telecare 2006, 12(3): 141-5.
16. Reeves, M.J., Arora, S., Broderick, J.P. et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005, 36(6): 1232-40.
17. Harwell, T.S., Blades, L.L., Oser, C.S. et al. Perceived risk for developing stroke among older adults. Prev Med 2005, 41(3-4): 791-4.
18. Zerwic, J., Hwang, S.Y., Tucco, L. Interpretation of symptoms and delay in seeking treatment by patients who have had a stroke: exploratory study. Heart Lung 2007, 36(1): 25-34.
19. Bambauer, K.Z., Johnston, S.C., Bambauer, D.E., Zivin, J.A. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol 2006, 63(5): 661-4.
20. Certification statistics through December 31, 2009. American Board of Psychiatry and Neurology, Inc., http://www.abpn.com/cert-statistics.htm. Accessed November 30, 2010.
21. McConnell, K.J., Johnson, L.A., Arab, N., Richards, C.F., Newgard, C.D., Edlund, T. The on-call crisis: a statewide assessment of the costs of providing on-call specialist coverage. Ann Emerg Med 2007, 49(6): 727-33.
22. McConnell, K.J., Newgard, C.D., Lee, R. Changes in the cost and management of emergency department on-call coverage: evidence from a longitudinal statewide survey. Ann Emerg Med 2008, 52(6): 635-42.
23. O'Malley, A.S., Draper, D.A., Felland, LE. Hospital emergency on-call coverage: is there a doctor in the house? Issue Brief Cent Stud Health Syst Change 2007(115): 1-4.
24. Rudkin, S.E., Langdorf, M.I., Oman, J.A., Kahn, C.A., White, H., Anderson, C.L. The worsening of ED on-call coverage in California: 6-year trend. Am J Emerg Med 2009, 27(7): 785-91.
25. Alberts, M.J., Hademenos, G., Latchaw, R.E. et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000, 283(23): 3102-9.
26. Lattimore, S.U., Chalela, J., Davis, L. et al. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience. Stroke 2003, 34(6): e55-7.
27. Albright, K.C., Branas, C.C., Meyer, B.C., Matherne-Meyer, D.E., Zivin, J.A., Lyden, P.D., Carr, B.G. ACCESS: acute cerebrovascular care in emergency stroke systems. Arch Neurol 2010, 67(10): 1210-8.
28. Kleindorfer, D., Xu, Y., Moomaw, C.J., Khatri, P., Adeoye, O., Hornung, R. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke 2009, 40(11): 3580-4.
29. Bradley, W.G. Neurology in the next two decades: report of the Workforce Task Force of the American Academy of Neurology. Neurology 2000, 54(4): 787-9.
30. Frey, J.L., Jahnke, H.K., Goslar, P.W., Partovi, S., Flaster, M.S. tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology 2005, 64(1): 154-6.
31. Merino, J.G., Silver, B., Wong, E. et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 2002, 33(1): 141-6.
32. Grotta, J.C., Burgin, W.S., El-Mitwalli, A. et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001, 58(12): 2009-13.
33. Audebert, H.J., Kukla, C., Clarmann von Claranau, S. et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005, 36(2): 287-91.
34. Wiborg, A., Widder, B. Teleneurology to improve stroke care in rural areas: The Telemedicine in Stroke in Swabia (TESS) Project. Stroke 2003, 34(12): 2951-6.
35. Switzer, J.A., Levine, S.R., Hess, D.C. Telestroke 10 years later - 'telestroke 2.0.' Cerebrovasc Dis 2009, 28(4): 323-30.
36. Hess, D.C., Wang, S., Hamilton, W. et al. REACH: clinical feasibility of a rural telestroke network. Stroke 2005, 36(9): 2018-20.
37. Steinbrook, R. The age of teleradiology. N Engl J Med 2007, 357(1): 5-7.
38. Josephson, S.A., Hills, N.K., Johnston, S.C. NIH Stroke Scale reliability in ratings from a large sample of clinicians. Cerebrovasc Dis 2006, 22(5-6): 389-95.
39. Handschu, R., Littmann, R., Reulbach, U., Gaul, C., Heckmann, J.G., Neundorfer, B., Scibor, M. Telemedicine in emergency evaluation of acute stroke: interrater agreement in remote video examination with a novel multimedia system. Stroke 2003, 34(12): 2842-6.
40. Meyer, B.C., Lyden, P.D., Al-Khoury, L. et al. Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology 2005, 64(6): 1058-60.
41. Shafqat, S., Kvedar, J.C., Guanci, M.M., Chang, Y., Schwamm, L.H. Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke 1999, 30(10): 2141-5.
42. Wang, S., Lee, S.B., Pardue, C. et al. Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke 2003, 34(10): e188-91.
43. Levine, S. Telemedicine increases options for successful stroke treatment: Nuts and bolts. 62nd Annu Meet Am Acad Neurol (April 10-17, Toronto) 2010, 4LS.002.
44. Goldstein, L.B., Matchar, D.B., Hoff-Lindquist, J., Samsa, G.P., Horner, R.D. VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. Neurology 2003, 61(6): 792-6.
45. Bose, A., Henkes, H., Alfke, K. et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008, 29(7): 1409-13.
46. Smith, W.S., Sung, G., Saver, J. et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008, 39(4): 1205-12.
47. Hofmeijer, J., Kappelle, L.J., Algra, A., Amelink, G.J., van Gijn, J., van der Worp, H.B. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009, 8(4): 326-33.
48. Rosenfeld, B.A., Dorman, T., Breslow, M.J. et al. Intensive care unit telemedicine: alternate paradigm for providing continuous intensivist care. Crit Care Med 2000, 28(12): 3925-31.
49. Ickenstein, G.W., Isenmann, S., Fiehler, J., Gahn, G., Schumacher, M., Klisch, J. Thrombolysis in neuromedicine: Bridging concepts for the management of acute brain infarction with occlusion of intracranial vessels. Clin Neuroradiol 2008, 18: 88-97.
50. Furlan, A., Higashida, R., Wechsler, L. et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282(21): 2003-11.
51. Smith, W.S., Sung, G., Starkman, S. et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36(7): 1432-8.
52. del Zoppo, G.J., Poeck, K., Pessin, M.S. et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992, 32(1): 78-86.
53. Zangerle, A., Kiechl, S., Spiegel, M. et al. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology 2007, 68(1): 39-44.
54. Bhatia, R., Hill, M.D., Shobha, N. et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010, 41(10): 2254-8.
55. Khatri, P., Hill, M.D., Palesch, Y.Y. et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008, 3(2): 130-7.
56. The Interventional Management of Stroke (IMS) II Study. Stroke 2007, 38(7): 2127-35.
57. Goyal, M., Menon, B.K., Coutts, S.B., Hill, M.D., Demchuk, A.M. Effect of baseline CT scan appearance and time to recanalization on clinical outcomes in endovascular thrombectomy of acute ischemic strokes. Stroke 2011, 42(1): 93-7.
58. Ickenstein, G.W., Gross, S., Tenckhoff, D., Hausn, P., Becker, U., Klisch, J., Isenmann, S. An empirical analysis of the current need for teleneuromedical care in German hospitals without neurology departments. Int J Telemed Appl 2010, 2010: 916868.
59. Pfefferkorn, T., Holtmannspotter, M., Schmidt, C. et al. Drip, ship, and retrieve: cooperative recanalization therapy in acute basilar artery occlusion. Stroke 2010, 41(4): 722-6.
60. Switzer, J.A., Hall, C.E., Close, B., Nichols, F.T., Gross, H., Bruno, A., Hess, D.C. A telestroke network enhances recruitment into acute stroke clinical trials. Stroke 2010, 41(3): 566-9.
61. Weintraub, M.I. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke 2006, 37(7): 1917-22.
62. Demaerschalk, B.M., Hwang, H.M., Leung, G. Cost analysis review of stroke centers, telestroke, and rt-PA. Am J Manag Care 2010, 16(7): 537-44.
63. Fagan, S.C., Morgenstern, L.B., Petitta, A. et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998, 50(4): 883-90.
64. Ehlers, L., Muskens, W.M., Jensen, L.G., Kjolby, M., Andersen, G. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness. CNS Drugs 2008, 22(1): 73-81.
65. Demaerschalk, B.M., Miley, M.L., Kiernan, T.E. et al. Stroke telemedicine. Mayo Clin Proc 2009, 84(1): 53-64.
66. Schwamm, L.H., Audebert, H.J., Amarenco, P. et al. Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke 2009, 40(7): 2635-60.